ivWatch on How Infusion Pump Companies Risk Patient Safety

ivWatch Executive Vice President of Sales and Business Development, Scott Hensley, addresses an infusion pump pressure alarm misconception in the area of infiltration detection, and its potential for patient harm in the MedTech Intelligence article, “Product Myths Put Patient Safety at Risk.” He discusses the importance of transparency from the medical device industry to hospitals, so they are best equipped to use technology to impact and provide better clinical outcomes for the patient. Read the full article here.

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

[fc id='6'][/fc]

You have Successfully Subscribed!

Pin It on Pinterest